Scientists at the IMBA – Institute of Molecular Biotechnology at the Austrian Academy of Sciences have succeeded in simulating congenital immunodeficiency syndrome in mice and identifying a possibility for its treatment. The researchers have now…

In the up-to-the-minute field of stem cell research, researchers at the IMBA – Institute of Molecular Biotechnology at the Austrian Academy of Sciences – are causing a stir with two discoveries: when stem cells are no longer needed, they starve…

Leonie Ringrose's group has shown that an epigenetic regulatory DNA element switches its function reversibly between activation and silencing, by switching the strand of its non coding transcription. Remarkably, the two strands work by different…

Martin Moder, microbiologist in the group of Jürgen Knoblich, has won the European Science Slam finale held by the Euroscience Open Forum (ESOF) in Copenhagen.

The geneticist has been honored for his scientific achievements in the fields of biomedicine and disease pattern research.

Scientists at IMBA have identified the final component that turns the RNA ligase into a fully viable enzyme in humans. That opens up perspectives for new treatment strategies for numerous types of breast cancer and leukemia.

IMBA Group Leader Kikue Tachibana-Konwalski is among the eight new members of the ÖAW’s Young Academy who have been appointed in this year’s election meeting. The new members will officially receive their degrees during the ceremonial meeting on…

IMBA Senior Scientist Julius Brennecke is awarded the life-long membership by EMBO, the European Molecular Biology Organization. With a membership in its organization EMBO recognizes outstanding research contributions and input to promote excellence…

The publication "What are memories made of? How Polycomb and Trithorax proteins mediate epigenetic memory." by IMBA Group Leader Leonie Ringrose is ranked No.1 on the top ten charts of Nature Reviews Molecular Cell Biology.

An international team including researchers from the Institute of Molecular Biotechnology (IMBA) of the Austrian Academy of Sciences has found a new neurodegenerative syndrome in children that coincides with disorders of the brain and peripheral…